Studies have shown that COL1A1 overexpression is strongly linked to malignant phenotypes, increased invasiveness, and poor prognosis in several cancers, including gastric cancer [15, 16], breast cancer [17, 18], pancreatic ductal adenocarcinoma [19], and lung cancer [20]. This evidence concerns the gene COL1A1 and breast cancer.